Roszdravnadzor will check complaints about double overpricing of diabetes drug

Roszdravnadzor will check complaints about double overpricing of diabetes drug

13 марта 2023, 12:30
Representatives of Roszdravnadzor will check the information published in the media about the overpricing by pharmacies of prices for a vital diabetes drug "Ozempik".

This is reported by RIA Novosti, the security forces have identified a network of pharmacies that sell the drug for diabetes "Ozempik" at 2-3 times inflated prices. Meanwhile, overpricing it is unacceptable, since it is included in the list of vital and essential medicines.

According to media reports, the drug should be sold at retail for no more than 7.7 thousand rubles, and it is often sold for 17-20 thousand.

As reported in Roszdravnadzor, following the results of the inspection, strict measures can be taken against violators in accordance with the law.

Earlier it was reported that against the background of the military operation of the Russian Federation on the territory of Ukraine, complaints about the shortage of medicines, including re-emergency, have become more frequent from many regions of the country.

#Health #Prices #Medicine #List of medicines #Deficit #Medicines #Price growth #Russia #Money #Price #Russians #Society #Healthcare
Подпишитесь